Intranasal Insulin Enhanced Resting-State Functional Connectivity of Hippocampal Regions in Type 2 Diabetes

Type 2 diabetes mellitus (T2DM) alters brain function and manifests as brain atrophy. Intranasal insulin has emerged as a promising intervention for treatment of cognitive impairment. We evaluated the acute effects of intranasal insulin on resting-state brain functional connectivity in older adults with T2DM. This proof-of-concept, randomized, double-blind, placebo-controlled study evaluated the effects of a single 40 IU dose of insulin or saline in 14 diabetic and 14 control subjects. Resting-state functional connectivity between the hippocampal region and default mode network (DMN) was quantified using functional MRI (fMRI) at 3Tesla. Following insulin administration, diabetic patients demonstrated increased resting-state connectivity between the hippocampal regions and the medial frontal cortex (MFC) as compared with placebo (cluster size: right, P = 0.03) and other DMN regions. On placebo, the diabetes group had lower connectivity between the hippocampal region and the MFC as compared with control subjects (cluster size: right, P = 0.02), but on insulin, MFC connectivity was similar to control subjects. Resting-state connectivity correlated with cognitive performance. A single dose of intranasal insulin increases resting-state functional connectivity between the hippocampal regions and multiple DMN regions in older adults with T2DM. Intranasal insulin administration may modify functional connectivity among brain regions regulating memory and complex cognitive behaviors.

[1]  G. Williams,et al.  Insulin receptors are widely distributed in human brain and bind human and porcine insulin with equal affinity , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[2]  C. Rowe,et al.  Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care 2013;36:2981–2987 , 2013, Diabetes Care.

[3]  T. Montine,et al.  Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial , 2011 .

[4]  Jens C. Brüning,et al.  The role of insulin receptor signaling in the brain , 2005, Trends in Endocrinology & Metabolism.

[5]  L. Hanson,et al.  Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease , 2008, BMC Neuroscience.

[6]  R. G. Thorne,et al.  Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration , 2004, Neuroscience.

[7]  William A Banks,et al.  Brain meets body: the blood-brain barrier as an endocrine interface. , 2012, Endocrinology.

[8]  Andrea M Philipp,et al.  The role of inhibition in task switching: A review , 2010, Psychonomic bulletin & review.

[9]  C. Hölscher,et al.  Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence , 2013, CNS Drugs.

[10]  Suzanne Craft,et al.  Insulin resistance syndrome and Alzheimer's disease: Age- and obesity-related effects on memory, amyloid, and inflammation , 2005, Neurobiology of Aging.

[11]  J. Reddon,et al.  Normative data stratified by age and sex for 12 neuropsychological tests , 1986 .

[12]  Jan Born,et al.  Sniffing neuropeptides: a transnasal approach to the human brain , 2002, Nature Neuroscience.

[13]  D. Figlewicz.  Insulin, food intake, and reward. , 2003, Seminars in clinical neuropsychiatry.

[14]  R. Veit,et al.  Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions , 2012, Diabetologia.

[15]  N. Birbaumer,et al.  The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: A magnetoencephalographic study , 2006, Proceedings of the National Academy of Sciences.

[16]  J. Born,et al.  Intranasal Insulin to Improve Memory Function in Humans , 2007, Neuroendocrinology.

[17]  I. Harman-boehm,et al.  Effect of intranasal insulin on cognitive function: a systematic review. , 2012, The Journal of clinical endocrinology and metabolism.

[18]  Vinod Menon,et al.  Functional connectivity in the resting brain: A network analysis of the default mode hypothesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Christian Gaser,et al.  Advanced BrainAGE in older adults with type 2 diabetes mellitus , 2013, Front. Aging Neurosci..

[20]  R. Veit,et al.  Central Insulin Administration Improves Whole-Body Insulin Sensitivity via Hypothalamus and Parasympathetic Outputs in Men , 2014, Diabetes.

[21]  Marek Kubicki,et al.  Cerebral White Matter Integrity and Resting-State Functional Connectivity in Middle-aged Patients With Type 2 Diabetes , 2014, Diabetes.

[22]  C. Messier,et al.  The Role of Insulin, Insulin Growth Factor, and Insulin-Degrading Enzyme in Brain Aging and Alzheimer's Disease , 2005, Neural plasticity.

[23]  M. Shenton,et al.  Resting-State Brain Functional Connectivity Is Altered in Type 2 Diabetes , 2012, Diabetes.

[24]  Paul J. Laurienti,et al.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.

[25]  S. Benoit,et al.  Insulin, leptin, and food reward: update 2008. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[26]  René Westerhausen,et al.  Intranasal insulin increases regional cerebral blood flow in the insular cortex in men independently of cortisol manipulation , 2014, Human brain mapping.

[27]  C. Rowe,et al.  Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin , 2013, Diabetes Care.

[28]  Michael W. Cole,et al.  The role of default network deactivation in cognition and disease , 2012, Trends in Cognitive Sciences.

[29]  B. Wróblewska,et al.  The binding of insulin to cerebral capillaries and astrocytes of the rat , 1982, Neurochemical Research.

[30]  J. Born,et al.  Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. , 2008, The Journal of clinical endocrinology and metabolism.

[31]  Sophie Schwartz,et al.  Role of frontal versus temporal cortex in verbal fluency as revealed by voxel-based lesion symptom mapping , 2006, Journal of the International Neuropsychological Society.

[32]  Manfred Hallschmid,et al.  Intranasal Insulin Suppresses Food Intake via Enhancement of Brain Energy Levels in Humans , 2012, Diabetes.

[33]  Ralph H. B. Benedict,et al.  Revision of the Brief Visuospatial Memory Test: Studies of normal performance, reliability, and validity. , 1996 .

[34]  M. Abbott,et al.  The Insulin Receptor Tyrosine Kinase Substrate p58/53 and the Insulin Receptor Are Components of CNS Synapses , 1999, The Journal of Neuroscience.

[35]  Ilya M. Veer,et al.  Endogenous cortisol is associated with functional connectivity between the amygdala and medial prefrontal cortex , 2012, Psychoneuroendocrinology.

[36]  William A Banks,et al.  The source of cerebral insulin. , 2004, European journal of pharmacology.

[37]  J. Born,et al.  Immediate but not long-term intranasal administration of insulin raises blood pressure in human beings. , 2005, Metabolism: clinical and experimental.

[38]  Karen L. Siedlecki,et al.  Evaluation of prefrontal–hippocampal effective connectivity following 24 hours of estrogen infusion: An FDG-PET study , 2008, Psychoneuroendocrinology.

[39]  M. Greicius,et al.  Resting-state functional connectivity reflects structural connectivity in the default mode network. , 2009, Cerebral cortex.

[40]  Yuan Feng,et al.  Aberrant Brain Functional Connectivity Related to Insulin Resistance in Type 2 Diabetes: A Resting-State fMRI Study , 2014, Diabetes Care.

[41]  B. Winblad,et al.  Diabetes mellitus and risk of dementia in the Kungsholmen project , 2004, Neurology.

[42]  Martin Klein,et al.  Resting-State Brain Networks in Type 1 Diabetic Patients With and Without Microangiopathy and Their Relation to Cognitive Functions and Disease Variables , 2012, Diabetes.

[43]  E. Stice,et al.  The contribution of brain reward circuits to the obesity epidemic , 2013, Neuroscience & Biobehavioral Reviews.

[44]  J. Brüning,et al.  Central insulin action in energy and glucose homeostasis. , 2006, The Journal of clinical investigation.

[45]  H. Schiöth,et al.  Intranasal Treatment of Central Nervous System Dysfunction in Humans , 2012, Pharmaceutical Research.

[46]  Habib Benali,et al.  Age-related changes in functional network connectivity associated with high levels of verbal fluency performance , 2014, Cortex.

[47]  P. Novak,et al.  Enhancement of Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes , 2014, Diabetes Care.

[48]  L. Schwabe,et al.  Intranasal insulin attenuates the hypothalamic–pituitary–adrenal axis response to psychosocial stress , 2008, Psychoneuroendocrinology.

[49]  Jan Born,et al.  Intranasal insulin improves memory in humans , 2004, Psychoneuroendocrinology.

[50]  S. Craft.  Insulin resistance and cognitive impairment: a view through the prism of epidemiology. , 2005, Archives of neurology.